SUPERIOR PRIMA SUKSES TBK (BLES.JK)
IDR 250.0
(-0.8%)
IDR 250.0
(-0.8%)
| Breakdown | 2023 | 2022 | 2021 |
|---|---|---|---|
| Operating Cash Flow | - | - | - |
| Net Income | - | - | - |
| Depreciation & Amortization | - | - | - |
| Deferred income taxes | - | - | - |
| Stock-based compensation | - | - | - |
| Change in working capital | - | - | - |
| Other non-cash items | - | - | - |
| Investing Cash Flow | -219.4 Billion | -80.73 Billion | -249.51 Billion |
| Investments in PPE | -213.1 Billion | -76.26 Billion | -243.49 Billion |
| Acquisitions | - | - | - |
| Investment purchases | - | - | - |
| Sales/Maturities of investments | - | - | - |
| Other Investing Activities | -7.08 Billion | -5.26 Billion | -6.39 Billion |
| Financing Cash Flow | 83.63 Billion | -93.49 Billion | 129.1 Billion |
| Debt repayment | -26.42 Billion | -17.17 Billion | -87.86 Billion |
| Dividends payments | -60 Billion | -50 Billion | - |
| Common Stock Repurchased | - | - | - |
| Common Stock Issuance | 140.24 Billion | - | 12.76 Billion |
| Other Financing Activities | -10.12 Billion | -42.86 Billion | 47.5 Billion |
| Accounts receivables | - | - | - |
| Accounts payables | - | - | - |
| Inventory | - | - | - |
| Other working capital | - | - | - |
| Cash at beginning of period | 5.67 Billion | 14.63 Billion | 13.02 Billion |
| Cash at end of period | 194.36 Billion | 5.67 Billion | 14.63 Billion |
| Capital Expenditure | -213.1 Billion | -76.26 Billion | -243.49 Billion |
| Effect of forex changes on cash | - | - | - |
| Net cash flow / Change in cash | 188.69 Billion | -8.96 Billion | 1.6 Billion |
| Free Cash Flow | -213.1 Billion | -76.26 Billion | -243.49 Billion |
| Breakdown | 2023 FY | 2023 Q4 | 2022 FY | 2021 FY |
|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - |
| Net Income | - | - | - | - |
| Depreciation & Amortization | - | - | - | - |
| Deferred income taxes | - | - | - | - |
| Stock-based compensation | - | - | - | - |
| Change in working capital | - | - | - | - |
| Other non-cash items | - | - | - | - |
| Investing Cash Flow | -219.4 Billion | -98.88 Billion | -80.73 Billion | -249.51 Billion |
| Investments in PPE | -213.1 Billion | -94.28 Billion | -76.26 Billion | -243.49 Billion |
| Acquisitions | - | - | - | - |
| Investment purchases | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - |
| Other Investing Activities | -7.08 Billion | -4.6 Billion | -5.26 Billion | -6.39 Billion |
| Financing Cash Flow | 83.63 Billion | 113.14 Billion | -93.49 Billion | 129.1 Billion |
| Debt repayment | -26.42 Billion | -23.21 Billion | -17.17 Billion | -87.86 Billion |
| Dividends payments | -60 Billion | - | -50 Billion | - |
| Common Stock Repurchased | - | - | - | - |
| Common Stock Issuance | 140.24 Billion | 135 Billion | - | 12.76 Billion |
| Other Financing Activities | -10.12 Billion | 1.35 Billion | -42.86 Billion | 47.5 Billion |
| Accounts receivables | - | - | - | - |
| Accounts payables | - | - | - | - |
| Inventory | - | - | - | - |
| Other working capital | - | - | - | - |
| Cash at beginning of period | 5.67 Billion | 69.09 Billion | 14.63 Billion | 13.02 Billion |
| Cash at end of period | 194.36 Billion | 194.36 Billion | 5.67 Billion | 14.63 Billion |
| Capital Expenditure | -213.1 Billion | -94.28 Billion | -76.26 Billion | -243.49 Billion |
| Effect of forex changes on cash | - | - | - | - |
| Net cash flow / Change in cash | 188.69 Billion | 125.27 Billion | -8.96 Billion | 1.6 Billion |
| Free Cash Flow | -213.1 Billion | -94.28 Billion | -76.26 Billion | -243.49 Billion |
CEREBRAINT
VRANDA
3845
5261
ANFGF
7723